These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 889685)

  • 1. Cell survival in B16 melanoma after treatment with combinations of cytotoxic agents: lack of potentiation.
    Stephens TC; Peacock JH; Steel GG
    Br J Cancer; 1977 Jul; 36(1):84-93. PubMed ID: 889685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell yield and cell survival following chemotherapy of the B16 melanoma.
    Stephens TC; Peacock JH
    Br J Cancer; 1978 Nov; 38(5):591-8. PubMed ID: 728348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of growth delay and cell survival as end-points of tumour response following treatment with combinations of cytotoxic agents.
    Stephens TC; Peacock JH
    Br J Cancer Suppl; 1980 Apr; 4():288-93. PubMed ID: 6932938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation of anticancer agents by amphotericin B.
    Medoff G; Valeriote F; Dieckman J
    J Natl Cancer Inst; 1981 Jul; 67(1):131-5. PubMed ID: 6942183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A soft agar colony assay for Lewis lung tumour and B16 melanoma taken directly from the mouse.
    Courtenay VD
    Br J Cancer; 1976 Jul; 34(1):39-45. PubMed ID: 782495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour volume response, initial cell kill and cellular repopulation in B16 melanoma treated with cyclophosphamide and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.
    Stephens TC; Peacock JH
    Br J Cancer; 1977 Sep; 36(3):313-21. PubMed ID: 921888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity to cytotoxic agents of the EMT6 tumour in vivo: tumour volume versus in vitro plating. 1. Cyclophosphamide.
    Twentyman PR
    Br J Cancer; 1977 Feb; 35(2):208-17. PubMed ID: 836758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo enhancement of vincristine antitumor activity on B16 melanoma cells by calcium antagonist flunarizine.
    Bellelli A; Camboni C; de Luca G; Materazzi M; Mattioni M; Sezzi ML; Bellelli L
    Oncology; 1987; 44(1):17-23. PubMed ID: 3561923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bromodeoxyuridine improves the cytotoxic effect of cisplatin: a comparison with 5-fluorouracil.
    Chelladurai M; Lobocki CA; Sultani M; Hanna Y; Drelichman A; Pieper DR; McLaughlin PW
    Cancer Chemother Pharmacol; 1997; 40(6):463-8. PubMed ID: 9332459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the Lonidamine Potentiated Effect of Nitrogen Mustard Alkylating Agents on the Systemic Treatment of DB-1 Human Melanoma Xenografts in Mice.
    Nath K; Nelson DS; Putt ME; Leeper DB; Garman B; Nathanson KL; Glickson JD
    PLoS One; 2016; 11(6):e0157125. PubMed ID: 27285585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of 5-fluorouracil cytotoxicity by combining hyperthermia and dipyridamole in vitro.
    Maehara Y; Sakaguchi Y; Kusumoto T; Kusumoto H; Sugimachi K
    Anticancer Res; 1989; 9(4):967-9. PubMed ID: 2817823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonogenic response of cells of murine intestinal crypts to 12 cytotoxic drugs.
    Moore JV
    Cancer Chemother Pharmacol; 1985; 15(1):11-5. PubMed ID: 4006043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial synchronization of L1210 cells by 5-fluorouracil and its use in drug combinations.
    Bhuyan BK; Blowers CL; Neil GL; Bono VH; Day KJ
    Cancer Res; 1977 Sep; 37(9):3204-8. PubMed ID: 560250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The lung-colony assay: extension to the Lewis lung tumour and the B16 melanoma--radiosensitivity of B16 melanoma cells.
    Hill RP; Stanley JA
    Int J Radiat Biol Relat Stud Phys Chem Med; 1975 Apr; 27(4):377-87. PubMed ID: 1095507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic cytotoxicity of human recombinant tumour necrosis factor alpha combined with microtubule effectors.
    Baumgart J; Schlott B; Suehnel J; Vater W; Schulze W; Behnke D
    J Cancer Res Clin Oncol; 1991; 117(3):239-43. PubMed ID: 2033091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies of the effects of cyclophosphamide, vincristine, and prednisone on some hepatic oxidations and conjugations.
    Gurtoo HL; Gessner T; Culliton P
    Cancer Treat Rep; 1976 Sep; 60(9):1285-94. PubMed ID: 1016965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of L-2-oxothiazolidine-4-carboxylate on the cytotoxic activity and toxicity of cyclophosphamide in mice bearing B16F10 melanoma liver metastases.
    del Olmo M; Alonso-Varona A; Castro B; Calle Y; Bilbao P; Palomares T
    Melanoma Res; 2000 Apr; 10(2):103-12. PubMed ID: 10803710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of antitumor effect of cyclophosphamide by centrophenoxine.
    Kanzawa F; Hoshi A; Kuretani K
    Gan; 1971 Jun; 62(3):235-6. PubMed ID: 4398065
    [No Abstract]   [Full Text] [Related]  

  • 19. Preclinical studies and clinical correlation of the effect of alkylating dose.
    Frei E; Teicher BA; Holden SA; Cathcart KN; Wang YY
    Cancer Res; 1988 Nov; 48(22):6417-23. PubMed ID: 3180059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative assay for the radiosensitivity of malignant melanomas.
    Krishnan EC; Krishnan L; Schweiger GD; Jewell WR
    Melanoma Res; 1994 Jun; 4(3):151-5. PubMed ID: 7919959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.